Diagnostic test developer Talis Biomedical Corp. and certain officers and directors were hit with a securities class action Friday in California Northern District Court over the company's Feb. 2021 IPO. The court action, filed by Glancy Prongay & Murray and the Law Offices of Frank R. Cruz, accuses the defendants of concealing likely delays in the launch of a COVID-19 test. The suit also names JPMorgan, BofA Securities, Piper Sandler and BTIG in their roles as underwriters of the IPO. Counsel have not yet appeared for the defendants. The case is 3:22-cv-00105, Modrak v. Talis Biomedical Corporation et al.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250